CVE-2026-21980

MEDIUM EPSS 8.5%
Published Jan 20, 20265mo ago · Modified Jun 17, 20262w ago
6.5 CVSS 3.1
Medium
Find Similar
Published Jan 20, 2026 5mo ago
Last Modified Jun 17, 2026 2w ago

Description

Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Coding. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Coding accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Coding accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).

CVSS Details

Base Score
6.5
Exploitability
3.9
Impact
2.5
Vector string
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N
Attack Vector Network
Attack Complexity Low
Privileges Required None
User Interaction None
Scope Unchanged
Confidentiality Low
Integrity Low
Availability None

Threat Intelligence

EPSS Exploit Probability
8.5% percentile
Exploit & Patch Status
No Known Exploit
No Patch Available

Affected Products 1

VendorProductVersionRange
oraclelife_sciences_central_coding7.0.1.0any

References 1

  • oracle.com https://www.oracle.com/security-alerts/cpujan2026.html
    Vendor Advisory

Remediation

No remediation data recorded yet

Check vendor advisories and the NVD entry for patch availability.